CLSN : Analysis & Opinions

  1. Celsion Submits Study Protocol for Oncology Candidate - Analyst ...

    January 7, 2015
    Celsion Corporation (CLSN) announced that it has submitted a phase I study protocol for GEN-1 to the FDA.
  2. Re-Thinking Small-Caps: Will These 12 Stocks Make A Comeback?

    March 28, 2012
    Common knowledge dictates that small-cap stocks are inherently risky, and should be avoided under the pretense of a European ...
Trading Center